secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2023-04-13T23:59:59+00:00
Accession:  0001906324-23-000027
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho pre-announces Q1 revenue $840-850M; non-respiratory grows 5-7%
--------------------------------------------------------------------------

- Total preliminary Q1 revenue $840-850M; respiratory $262-267M including COVID-19 $212-217M.
- Non-respiratory revenue $578-583M, up ~5% supplemental combined basis (~7% constant currency).
- Labs business unit drove growth including ~$21M settlement from a collaboration agreement.
- CEO Douglas Bryant says Q1 ahead of expectations; confident in sustainable high-single-digit growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632423000027/0001906324-23-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632423000027/qdel-20230413.htm
  HTML page:      https://secwatch.observer/filing/0001906324-23-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer